Skip to content
Twitter Facebook-f Youtube Instagram Linkedin
NETs Info
Donate
Close Menu
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • International Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • Optimal Care Pathway
    • For Patients
    • For Health Professionals
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • Advocate for us
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us
Donate
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • International Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • Optimal Care Pathway
    • For Patients
    • For Health Professionals
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • Advocate for us
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us

Home » News » COVID-19 Information and Resources

COVID-19 Information and Resources

  • June 1, 2022

A note from our CEO on COVID-19:

To our wonderful NET community we stand with you and alongside you as we get through this unprecedented situation together. Please know we will do everything we can to support you, whilst working hard to ensure that services and treatment are uninterrupted. We know this is a difficult situation for everyone and anxiety is high but know we will do everything we can to help. 

If you are unsure about the current restrictions in your state, here is a helpful resource from Healthdirect.

We send love to all of our patients, carers, healthcare professionals and stakeholders in these unprecedented times.

Stay safe

Simone Leyden
CEO and Co-founder
Neuroendocrine Cancer Australia

A note from our NET Nurse on COVID-19:

There are a number of very helpful resources below, which will give you up-to-date information about what you can do to protect yourself and the community from Coronavirus (COVID-19). There are some particular points, which are very relevant to those with NETs, which I’d like to highlight:

  • Click here for current advice on antiviral treatments.
  • If you test positive to COVID-19, it is important to let your treating team know as soon as possible, because there are COVID-19 treatments available for immunocompromised people (including those with cancer). These treatments work best when they are given within 5-7 days after symptoms begin. Click here to learn more about how to manage your cancer care after a positive test result.

  • ATAGI “ Recommendations on the use of a 3rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised”  click here
  • What to do if you have COVID – easy guide for isolating and gateway to comprehensive FAQ info hub
  • What are COVID-19 rapid antigen tests (RATs) and where can I buy them?
  • How to prepare a kit to manage COVID-19 at home
  • COVID-19 Symptom Checker tool – updated to help people understand their symptoms and know when to seek medical help
  • Although many people with NETs may be more vulnerable to COVID-19, there is a large range of variation in terms of the types of tumours and treatments, it’s important to be guided, first and foremost, by information from your health care team.
  • One of the things that is clear in the research to date is that smoking is a significant risk factor for people having poorer outcomes with COVID-19. This is actually the case for those who do not also have cancer, however the rate of complications for those with cancer who smoke is very concerning. If you can, consider reducing or stopping smoking. For more information and resources, see www.quit.org.au/
  • We have received assurances about the stability of the supply chain for medicines that are used in the treatment of NETs. If people are on monthly somatostatin analogues (e.g. Sandostatin LAR or Lanreotide), and worried about leaving the home to attend clinics to have these injections, assistance may be available to have these administered at home. Speak to your specialist, or contact us via this link.
  • It is important that if you’re feeling unwell with symptoms that could be COVID-19, not to arrive unannounced at your cancer centre or clinic. If in doubt, get in touch with them for more advice.
  • It is recommended to have a concise summary of your illness and treatment available, in case you need to present to another health care provider. An ideal format for this is our NET Treatment and Wellness Plan.
  • For those who are having difficulty getting to the shops, several of the larger supermarket chains are now allowing those who are more vulnerable to access home delivery services.
  • Finally, and importantly, we know that having neuroendocrine tumours can be very stressful, regardless of other things. The impact of COVID-19, on top of this, may leave you, and those around you feeling very emotionally vulnerable. It is more important than ever to be gentle with yourself and others, and take the time to engage in all the things that you would normally do to keep yourself well, both physically and mentally. Exercise, eating well, connecting with others (even if this might mean learning a new computer skill) are vital at this time.

As Simone has said, we are here to support you, and this is not changing. We have many groups (which are now meeting online) – see our Support Groups page.

We are also providing more intensive support via our Facebook groups – you can find our main Private Discussion Group and our Private Carers Group at (once you click on “Join Group”, you will be guided to answer three questions, so we can approve your membership).

Please take care, wash your hands, and keep physically (but not socially) distancing. We’re all in this together, and we’re here to support each other through these challenging times.

Below is a list of resources that neuroendocrine patients, healthcare professionals and our community may find helpful:

General COVID-19 information and Cancer Care

  • Cancer Council: https://bit.ly/2xfsrUZ
  • Australian Government: https://bit.ly/2xg95iG
  • Health Direct: https://bit.ly/33GqYDe

NeuroEndocrine Cancer Australia Patient Support Groups

All of our patient support groups have temporarily moved online. Please follow the below link for further information:

  • https://neuroendocrine.org.au/patient-support-groups/

Managing COVID-19 stress and anxiety

  • Nurses Association: https://bit.ly/3dottyp

Social distancing and hygiene

  • Medical Journal of Australia on Social: https://bit.ly/2WCzl1h

Pharmaceutical updates

  • Medicines Australia: https://bit.ly/39awuPP

Clinical trial updates

  • Bellberry Guidance: https://bellberry.com.au/covid-19-and-clinical-trials/

Healthcare Professional Resources

  • Clinical Oncology Society of Australia (COSA): https://www.cosa.org.au/publications/covid-19-updates/
  • Medicine Australia: https://medicinesaustralia.com.au/covid-19/
  • VCCCP webinar series on “COVID-19 and Cancer in Victoria: Models of Care”

Additional Patient Resources

The Medical Journal of Australia have fast-tracked the publication of the following article, which draws together what health professionals and scientists know about managing people with cancer during the COVID-19 pandemic:

  • Medical Journal of Australia: Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance: https://bit.ly/2vZbk9L

There is a very useful  patient summary, which has been produced by several cancer patient organisations, including NeuroEndocrine Cancer Australia – you can find this at:

  • Medical Journal of Australia: Patient Summary: https://bit.ly/3aybIuP

Share this post

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

Australia & New Zealand Society of Nuclear Medicine (ANZSNM) Conference

May 30, 2023

Michael Usher joins NECA as an Ambassador

May 30, 2023

ENETS Conference 2023

March 27, 2023

Michael Doyle Live Wake Fundraiser

February 4, 2023
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousNeuroEndocrine Cancer Australia & Macquarie University study on important online resources for NET patients.
NextThe Future of Precision Oncology in Nuclear Medicine – ReportNext

Related Posts

Australia & New Zealand Society of Nuclear Medicine (ANZSNM) Conference

The Australia & New Zealand Society of Nuclear Medicine (ANZSNM) conference was held in Adelaide 26 – 28 May 2023. There was a Pre-Conference Symposium

Michael Usher joins NECA as an Ambassador

We a thrilled to introduce Michael Usher as an ambassador for NeuroEndocrine Cancer Australia. Widely regarded as one of the country’s foremost broadcast journalists, Michael is

ENETS Conference 2023

ENETs was held in Vienna at the Austria Centre from 22 – 24 March 2023. There were 850 attending the conference in person from all

Michael Doyle Live Wake Fundraiser

On Saturday February 4th our Consumer Advisory Group member for Western Australia, Michael Doyle not only celebrated his 65th birthday but also held a “live

View All

Make a difference

How much do you wish to donate?
$50
$100
$250
$500
$1000
Other
NeuroEndocrine Cancer Australia logo white
Twitter Facebook-f Youtube Instagram Linkedin

All donations are tax deductible.
Registered Charity CFN 202607

Who We Are

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Neuroendocrine Cancers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

For Patients

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise

© 2020 NeuroEndocrine Cancer Australia

  • Website by Five Creative